SCHEMBL2297980

SCHEMBL2297980

O=C1NCCN1c1ccc(S(=O)(=O)O)c(-c2ccc(Cl)cc2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.36
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
KMT2A Q03164 1/20 0.36
ALOX5 P09917 2/20 0.36
MAPT P10636 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
RAB9A P51151 1/20 0.36
EIF2AK2 P19525 1/20 0.35
PARP1 P09874 2/20 0.35
ENPP2 Q13822 1/20 0.35
SUV39H2 Q9H5I1 2/20 0.34
USP2 O75604 1/20 0.34
TDO2 P48775 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA4 P22748 1/20 0.33
CA7 P43166 1/20 0.33
PTGS2 P35354 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14119618 0.93 SLC6A2 (0.36) PKMMEN1LMNAKMT2AALOX5
SCHEMBL2301831 0.90 MEN1 (0.36) PKMMEN1LMNAKMT2AALOX5
SCHEMBL2300754 0.89 ALDH1A1 (0.35) MEN1LMNAKMT2AMAPTCYP2C9
SCHEMBL2307068 0.89 TDO2 (0.40) MAPTEIF2AK2PARP1TDO2
SCHEMBL2303530 0.89 PDK2 (0.34) MEN1LMNAKMT2AEIF2AK2SUV39H2
SCHEMBL2302675 0.88 ALOX5 (0.42) PKMMEN1LMNAKMT2AALOX5
SCHEMBL2236723 0.88 KMT2A (0.34) MEN1KMT2AALOX5RAB9AEIF2AK2
SCHEMBL2306916 0.88 TDO2 (0.35) MEN1LMNAKMT2AEIF2AK2SUV39H2
SCHEMBL2305060 0.88 CA1 (0.40) PKMALOX5RAB9APARP1ENPP2
SCHEMBL2303927 0.88 EIF2AK2 (0.43) MEN1LMNAKMT2AALOX5MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9034888-B2 Substituted 2-imidazolidones and analogs UNIVERSITE LAVAL (CA) 2015-05-19 US disclosed
EP-2536693-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS Université Laval (CA) 2012-12-26 EP disclosed
US-20120309777-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS UNIVERSITE LAVAL (CA) 2012-12-06 US disclosed
WO-2011100840-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS UNIVERSITé LAVAL (CA) 2011-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120309777-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS CCNY, RPS4Y1, TPX2 PKM 2928/4885MEN1 1673/4885LMNA 2765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.